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Abstract
The effects of alveolar large aggregate (LA) and small aggregate (SA) surfactant subfractions isolated from healthy adult
rats on mitogen-stimulated proliferative responses of human peripheral blood mononuclear cells (PBMC) was examined.
Various concentrations of total surfactant suppressed proliferation of stimulated lymphocytes by up to 95% of mitogen-
stimulated cells alone. LA subfractions of total surfactant had no effect on proliferation, whereas SA significantly enhanced
the lymphocyte proliferation at lower concentrations (7.8 Wg/ml) compared to mitogen-stimulated cells alone. Higher
concentrations of SA (62.5 Wg/ml) inhibited lymphocyte proliferation. This concentration-dependent effect of SA on
proliferation of PBMC was also present when cells were stimulated with various lectins including anti-CD3, concanavalin A
and phytohemagglutinin. Analysis of the supernatant of mitogen-stimulated cell cultures treated with inhibitory
concentrations of SA showed decreased amounts of interleukin (IL)-2, compared to cells alone, which could be reversed
by adding exogenous IL-2 to the cell cultures with the SA. These results suggest that alveolar surfactant subfractions have
distinct functions within the alveoli, both biophysically and with respect to their effects on the host’s immunomodulatory
responses. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Pulmonary surfactant isolated from broncho al-
veolar lavage can be separated into two distinct sub-
types [1,2], designated as large surfactant aggregates
(LA) and small aggregates (SA) [3]. LA represent
freshly secreted surfactant in large lamella or tubular
myelin-like forms and are responsible for maintain-
ing alveolar stability by reducing the surface tension
at the air^liquid interface. SA are small vesicular
forms, which are not surface active and have been
shown to be the metabolic products of LA formed
through a conversion process within the alveolar
space [4,5].
In addition to its biophysical role of lowering sur-
face tension, current evidence suggests that surfac-
tant may a¡ect the pulmonary in£ammatory re-
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sponse and participate in immune regulation within
the lung. Previous studies have shown for example,
that whole surfactant, as well as individual compo-
nents of surfactant can in£uence the function of lym-
phocytes. Alveolar lymphocytes obtained from lungs
via broncho alveolar lavage are relatively hypores-
ponsive to various mitogens in comparison to lym-
phocytes isolated from peripheral blood [6]. These
di¡erences presumably serve to protect the host
from chronic alveolar immune-cell activation, which
potentially would lead to progressive lung damage.
Since pulmonary surfactant lines the alveolar space
and is in close proximity to both alveolar and vas-
cular cellular populations, it is reasonable to assume
that the presence of an intact endogenous surfactant
system is important for lung homeostasis, and may
therefore in£uence lymphocyte activation and prolif-
eration.
Recent in vitro studies have shown that both the
phospholipid and surfactant-associated proteins
(SP-) SP-A and SP-D altered lymphocyte function
[7,8]. We have previously shown that mitogen-in-
duced lymphocyte proliferation was inhibited when
these cells were pre-incubated with puri¢ed bovine
SP-A [7]. Subsequent studies demonstrated that SP-
D also inhibited lectin and anti-CD3-stimulated pro-
liferation of human peripheral blood mononuclear
cells (PBMC) [8]. Although these ¢ndings support
the hypothesis that surfactant plays an important
role in downregulating mitogen-induced lymphocyte
proliferation, the experimental approach utilized in
these studies was limited. For example, surfactant
does not exist as isolated lipid or protein components
within the airspace, but as a complex lipoprotein
mixture, which can be separated into large and small
aggregates. Indeed, it is possible that these complex
aggregate structures may alter the availability of the
individual surfactant components, speci¢cally the
surfactant-associated proteins, to various cellular
populations within the lung. The objective of the
current study therefore, was to characterize the ef-
fects of these di¡erent alveolar surfactant subfrac-
tions on mitogen-induced lymphocyte proliferation
to more adequately re£ect the interactions of alveolar
surfactant with these cells in vivo.
2. Materials and methods
2.1. Isolation of the surfactant aggregates
Total alveolar surfactant and alveolar surfactant
aggregate subfractions from four di¡erent groups
of normal adult (Wistar) rats were utilized for these
experiments. Whole lung lavage was performed in
healthy animals immediately after sacri¢ce using ster-
ile Tris-bu¡ered saline at room temperature. Ten ml
of this £uid was infused through the endotracheal
tube into the lungs until they were fully distended.
The £uid was then withdrawn and reinfused two
more times and this procedure was repeated a total
of ¢ve times for each animal. All lung lavage samples
were pooled and centrifuged at 150Ug for 10 min to
yield a pellet containing cellular debris. The 150Ug
supernatant was referred to as ‘total surfactant’.
Large aggregate (LA) and small aggregate (SA)
forms were isolated from the 150Ug supernatant,
via centrifugation of this material at 40 000Ug for
15 min at 4‡C. The LA pellet was resuspended in a
small volume of sterile, serum-free RPMI-1640 me-
dia and aliquots were removed for determination of
phosphorus content while the remainder of the sam-
ple was stored in separate aliquots at 370‡C until
further use. The 40 000Ug supernatant containing
the SA fraction was dialyzed against distilled deion-
ized water using a dialysis membrane with a molec-
ular mass cuto¡ of 6000^8000 Da, and then trans-
ferred into 50-ml sterile plastic centrifuge tubes and
concentrated by speed-vac. The SA powder was then
resuspended in a small volume of sterile, serum-free
media similar to the LA fractions, and aliquots were
obtained for phosphorus determination. The remain-
ing SA sample was frozen at 370‡C until further use.
Phospholipid content was measured by a modi¢ed
method of Duck-Chong [9] and composition was de-
termined by separating the various lipids via thin-
layer chromatography followed by phosphorus assay
[10]. The phospholipid composition was generally
similar between the two aggregate types, with the
sole exception of lysophosphatidylcholine which
comprised only 0.4 þ 0.3% of the large aggregates
whereas it was 2.3 þ 0.5% of the small aggregates
(P6 0.05).
Aliquots of the LA and SA fractions were resus-
pended in 0.15 M NaCl/1.5 mM CaCl2 to obtain a
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¢nal concentration of 2.5 mg of phospholipid/ml.
The surface tension-reducing activity of these sam-
ples was then assessed using a pulsating bubble sur-
factometer (Electronetics Corp., NY) as described by
Enhorning [11]. With this technique the surface ten-
sion-reducing ability of the LA was high, reducing
tension from an initial value 24.9 þ 1.2 to 4.8 þ 2.6
mN/m after 20 pulsations and this was further re-
duced to 0.7 þ 0.2 mN/m after 40 pulsations. With
the SA forms both basal surface tension was greater
at a value of 46.2 þ 1.7 mN/m and this was only
reduced to 27.3 þ 2.4 mN/m after some 40 pulsations.
At all points tested there was a signi¢cant (P6 0.05)
di¡erence between the values obtained from the two
di¡ering aggregate types, with the large aggregates
being superior throughout.
2.2. Surfactant protein (SP-A and SP-D) analyses
Similar quantities (based on phospholipid-phos-
phorus) of LA and SA fractions isolated from the
four di¡erent groups of rats utilized for these experi-
ments were subjected to a 12% polyacrylamide pro-
tein gel electrophoresis containing 0.1% sodium do-
decyl sulfate using the method of Laemmli [12]. After
electrophoresis, proteins were transferred to nitrocel-
lulose using a Bio-Rad transfer apparatus (Bio-Rad
Laboratories, Mississauga, ON, Canada). Transfer
was carried out at 100 V for 1 h. Western blot anal-
ysis was then performed using the nitrocellulose pa-
per that was blocked overnight with 3% milk in 50
mM Tris bu¡er at 4‡C and incubated with a primary
antibody in phosphate-bu¡ered saline (PBS)/0.2%
normal rat serum for 1 h. The primary antibodies
utilized for these experiments included a polyclonal
rabbit-anti-rat SP-D antibody (a generous gift of Dr
Jo Rae Wright, UNC, Chapel Hill, NC) and a poly-
clonal rabbit-anti-rat SP-A antibody (a generous gift
of Dr Fred Possmayer, UWO, London, ON, Cana-
da). Blots were then washed three times in PBS with
0.1% Tween-20 and incubated with the second anti-
body, horseradish peroxidase (HRP)-labeled donkey
anti-rabbit sera. After ECL (enhanced chemilumines-
cent) reagent development, the blots were exposed to
X-ray ¢lm (Eastman Kodak, Rochester, NY). The
ECL kit employed was purchased from Amersham
Life Science (Little Chalfont, Bucks, UK) and used
according to the instructions provided.
2.3. Isolation of lymphocytes
Human peripheral blood mononuclear cells
(PBMC) were obtained from healthy volunteers via
venipuncture and collected in 15-ml heparin-contain-
ing vacuum tubes (Becton Dickinson, Rutherford,
NJ, USA). The blood was diluted 1:1 in sterile tissue
culture media (RPMI-1640) containing penicillin
(100 Wg/ml), streptomycin (100 Wg/ml), amphoteri-
cin-B (2.5 Wg/ml), L-mercaptoethanol (5.5U1035
M), and gentamycin (0.1 Wg/ml) (Gibco BRL, Bur-
lington, ON, Canada). Ten ml of the diluted blood
sample was layered over 4.5 ml of Histopaque-1077
(Sigma, Oakville, ON, Canada) in 15-ml conical
tubes. Mononuclear cells were harvested from the
interface after centrifugation of these tubes at
400Ug for 40 min. PBMC were then washed two
times in 4‡C tissue culture media and resuspended
in sterile tissue culture media containing 10% (v/v)
newborn calf serum (Gibco BRL). Cells were cul-
tured at a concentration of 2U105 cells per well in
£at-bottomed, 96-well sterile plates (Corning, NY).
2.4. Lymphocyte proliferation assays
Three di¡erent T-lymphocyte cell mitogens, phyto-
hemagglutinin (PHA; 1 Wg/ml), concanavalin A (Con
A; 2 Wg/ml) (Sigma, St. Louis, MO), and anti-CD3
(UCHTI; 50 ng/ml; ID Labs, London, ON, Canada)
were used for these experiments. In separate experi-
ments, varying amounts of either total surfactant,
LA or SA (7.8, 15.6, 31.3 or 62.5 Wg phospholipid/
ml) were added to the lymphocytes together with the
mitogen in 96-well plates. The cultures were then
incubated at 37‡C with 5% CO2 in a humidi¢ed at-
mosphere for 64 h. At the 48-h time point, 1 WCi of
[3H]thymidine (Amersham International, Oakville,
ON, Canada) suspended in 50 Wl medium was added
to each well (speci¢c activity: 6.7 Ci/nmol). Cells
were then harvested at the 64-h time point with a
semiautomatic Skatron cell harvester (Sterling, VA)
and the ¢lter papers were allowed to dry. The
amount of [3H]thymidine incorporated into the
DNA was measured via liquid scintillation spectro-
photometry. Of note, cell viability was con¢rmed us-
ing both the Trypan blue exclusion technique, as well
as measuring the release of lactate dehydrogenase
from the cells (Sigma Diagnostics, St. Louis, MO).
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In some experiments, exogenous interleukin-2 (IL-2)
(RpD Systems, Minneapolis, MN) was added at
doses of either 10 or 100 IU/ml at the initiation of
the cell culture.
2.5. Interleukin-2 (IL-2) assay
In separate experiments, PBMC were isolated as
described above and cultured in 0.5 ml of RPMI-
1640 medium containing 10% (v/v) newborn calf se-
rum in 24-well £at-bottomed plates (Corning). Cells,
2U106 per well, were plated in the presence or ab-
sence of 50 ng/ml of anti-CD3 (UCHTI; ID Labs,
London, ON, Canada) and varying amounts of ei-
ther LA or SA (7.8, 15.6, 31.3, or 62.5 Wg phospho-
lipid/ml). After 24 h of culture, cells were then trans-
ferred into sterile Eppendorf tubes and centrifuged in
a microcentrifuge at 14 000 rpm for 1 min to precip-
itate cells and debris. The supernatants were frozen
at 370‡C until IL-2 assays were performed. Human
IL-2 enzyme-linked immunosorbent assay (ELISA)
kits were obtained from RpD Systems and used ac-
cording to the manufacturer’s speci¢cations. Each
culture condition was performed in triplicate and
the resultant supernatants were assayed in duplicate.
2.6. Statistics
Statistical analyses were performed by comparing
the results between positive control (cells with mito-
gen alone) and treated cell cultures (cells with mito-
gen and surfactant preparation) using a two-way
analysis of variance (ANOVA) with the Tukey post
hoc test. Comparisons between two experimental
groups were made using the Student’s t-test. A prob-
ability value of less than 0.05 was considered signi¢-
cant.
3. Results
Surfactant protein analyses are shown in Fig. 1.
When equal amounts of LA and SA phospholipid
were loaded onto gels, LA contained relatively
more detectable SP-A in all four batches of surfac-
tant utilized for these experiments than the SA frac-
tions (Fig. 1A). Moreover, among the four batches,
similar amounts of SP-A were detected with both LA
and SA samples respectively. In addition, Western
blot analysis showed that LA contained minimal
amounts of SP-D, whereas variable amounts of SP-
D were detected among the SA samples (Fig. 1B).
3.1. Proliferation assays
Di¡erent quantities of ‘total surfactant’ (i.e., be-
fore aggregate isolation) were tested for their e¡ects
on lymphocyte proliferation. These results are shown
in Fig. 2. Total surfactant had no e¡ect on lympho-
cyte proliferation at a concentration of 15.6 Wg
Fig. 1. Western blot analysis of the surfactant protein A and D in LA and SA. Di¡erent batches (1, 2, 3, 4) of normal rat LA and
SA with equivalent amounts of phospholipid (2.5 and 5.0 Wg, respectively) were electrophoresed on 12% SDS^PAGE gel, transferred
to the nitrocellulose membrane, and blotted with polyclonal anti-rat SP-A (A) and anti-rat SP-D (B) sera followed by HRP-labeled
donkey anti-rabbit antibody. The blots were exposed to X-ray ¢lm for 90 s.
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PL/ml, but signi¢cant inhibitory e¡ects were ob-
served at higher concentrations when compared to
the mitogen-stimulated control group (P9 0.05 vs.
31.3 and 62.5 Wg PL/ml).
The e¡ects of the individual surfactant subfrac-
tions on lymphocyte proliferation are shown in Fig.
3. Although LA had no signi¢cant e¡ects on anti-
CD3-stimulated lymphocyte proliferation at all con-
centrations tested (Fig. 3A), SA had signi¢cant con-
centration-dependent e¡ects (Fig. 3B). While lower
concentrations (7.8 Wg/ml) resulted in approximately
a 2-fold increase in lymphocyte proliferation, higher
concentrations (v 62.5 Wg/ml) inhibited lymphocyte
proliferation. In a separate experiment, samples of
both LA and SA were heated to 95‡C for 10 min
prior to adding these aggregates to cell cultures.
Heating had no e¡ect on the activity of these surfac-
tant subfractions with respect to lymphocyte prolif-
eration (results not shown). Furthermore, cell viabil-
ity testing performed at the ¢nal time point of all
cultures con¢rmed over 90% viability.
In order to examine if the observed e¡ects of SA
on lymphocyte proliferation were mitogen-speci¢c,
additional experiments were performed using di¡er-
ent T-cell mitogens (Fig. 4). Lymphocytes stimulated
with either Con A or PHA were also a¡ected by SA
in a similar concentration-speci¢c manner as those
observed with the anti-CD3 mitogen, although there
was some variability in the enhanced proliferative
e¡ect of SA at lower concentrations.
3.2. IL-2 assays and addition of exogenous IL-2
Fig. 5A shows IL-2 concentrations measured in
the supernatant obtained from cultured PBMCs, 24
h after anti-CD3 stimulation with or without various
amounts of SA added. Unstimulated culture cells
alone are indicated as CA. The pattern of the pro-
liferative response (Fig. 5B) in these experiments was
similar to those shown in Fig. 3B, and the amount of
IL-2 detected in the supernatant of the centrifuged
cells was signi¢cantly lower than the anti-CD3-stimu-
lated cells. Moreover, IL-2 levels were low even at
Fig. 2. Incorporation of [3H]thymidine into cultures of human
PBMC (2U105/well) stimulated with 50 ng/ml of anti-CD3
(UCHT1) in the absence or presence of increasing doses of to-
tal surfactant obtained from normal rats. Each bar represents
the mean þ S.E.M. of six determinations. CA (cells alone) repre-
sents the negative control. *P9 0.05, signi¢cantly di¡erent from
positive control cells plus CD-3.
Fig. 3. (A) Incorporation of [3H]thymidine into cultures of hu-
man PBMC (2U105/well) stimulated with 50 ng/ml of anti-CD3
(UCHT1) in the absence or presence of increasing concentra-
tions of large aggregates (LA; 40 000Ug pellet) obtained from
normal rat lung lavage. Each bar represents the mean þ S.E.M.
of six determinations. CA (cells alone) represents the negative
control. (B) Incorporation of [3H]thymidine into cultures of hu-
man PBMC (2U105/well) stimulated with 50 ng/ml of anti-CD3
(UCHT1) in the absence or presence of increasing concentra-
tions of small aggregate (SA; 40 000Ug supernatant) obtained
from normal rat lung lavage. Each bar represents the mean þ
S.E.M. of six determinations. CA (cells alone) represents the
negative control. *P9 0.05, signi¢cantly di¡erent from positive
control cells plus CD-3. #Signi¢cantly di¡erent (P9 0.05) from
* values.
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concentrations of SA which were shown to augment
lymphocyte proliferation.
Fig. 6 shows the results of experiments in which
exogenous IL-2 was added to the cell cultures. When
concentrations of either 10 IU/ml (Fig. 6A) or 100
IU/ml (Fig. 6B) of IL-2 were added to PBMC cul-
tures, the e¡ects of adding SA were abolished at all
concentrations up to 62.5 Wg/ml. Moreover, both
concentrations of IL-2 tested actually augmented
the anti-CD3 driven proliferative response, which
was approximately 3-fold at 10 IU/ml of IL-2, and
9-fold at 100 IU/ml compared to both anti-CD3 re-
sponses. These data suggest that exogenous IL-2 ei-
ther overcame or reversed the inhibitory e¡ects of
higher concentrations of SA on proliferation.
4. Discussion
Although the primary biophysical function of pul-
monary surfactant is to reduce surface tension at the
air^liquid interface, surfactant is also the ¢rst sub-
stance that inhaled pathogens encounter when depos-
ited within the alveoli. This fact, together with the
extensive in vitro data demonstrating that speci¢c
surfactant components may a¡ect cellular in£amma-
tory responses, suggests that an intact surfactant sys-
tem may protect the host from chronic immune re-
sponses to foreign particles. Initial studies evaluating
the e¡ects of surfactant components on host im-
mune-cell responses showed that the lipid component
of surfactant exhibited anti-in£ammatory properties
[13,14]. Speci¢cally, phosphatidylglycerol and phos-
phatidylcholine signi¢cantly inhibited cellular im-
mune function [15]. More recently, the two hydro-
philic surfactant-associated proteins, SP-A and SP-
D, have also been implicated in downregulating im-
mune responses [7,8]. The present study is the ¢rst to
evaluate the e¡ects of isolated surfactant aggregate
forms on these types of responses. Our results
showed that SA subfractions had a signi¢cant e¡ect
Fig. 4. Incorporation of [3H]thymidine into cultures of human
PBMC (2U105/well) stimulated with either 1.0 Wg/ml of conca-
navalin A (A), or 1.0 Wg/ml of phytohemagglutinin (B) in the
presence or absence in increasing doses of small aggregates
(SA; 40 000Ug supernatant) obtained from normal rat lung lav-
age. Each bar represents the mean þ S.E.M. of six determina-
tions. CA (cells alone) represents the negative control.
Fig. 5. Human PBMC (1U106/well) either untreated (cell alone;
CA) or stimulated with 50 ng/ml of anti-CD3 and cultured in
the presence or absence of increasing doses of small aggregates
for 24 h. The supernatants were assayed for soluble IL-2 using
a commercial enzyme-linked immunoassay (EIA) (A). A parallel
assay for proliferation was completed and the results are shown
in B. CA represents the untreated negative control. *P9 0.05,
signi¢cantly di¡erent from positive control cells stimulated with
CD-3.
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on lymphocyte proliferation depending on the con-
centrations used, whereas the LA subfractions had
no e¡ect on cellular proliferation in this assay sys-
tem.
The rationale for utilizing lymphocytes for these
experiments stems from data that suggest T lympho-
cytes play an important role in the host’s innate im-
mune response within the lung. For example, func-
tional T cells and the various mediators secreted
from these cells, including IL-2, regulate the in£ux
of other in£ammatory cells such as monocytes, neu-
trophils, and eosinophils into the lung in response to
a local insult. These latter cells are central to a host’s
in£ammatory response aimed at controlling or min-
imizing the deleterious e¡ects of the insult [16]. In
some situations, however, this alveolar in£ammatory
response may be overwhelming, resulting in acute
lung injury and respiratory failure. A clinical exam-
ple of such a condition is the acute respiratory dis-
tress syndrome (ARDS), which is characterized by
marked pulmonary in£ammation in response to a
variety of potential insults. Once established,
ARDS has a mortality of 40^60%. A number of oth-
er lung diseases also involve a signi¢cant alveolar
in£ammatory response, including interstitial pulmo-
nary ¢brosis, tuberculosis and sarcoidosis. These
conditions are all mediated via an upregulated de-
layed, hypersensitivity immune response that in-
volves T lymphocytes, and hence may be in£uenced
by alterations in the pulmonary surfactant system
[17]. Indeed, pulmonary surfactant alterations have
been demonstrated in patients with these various dis-
eases.
The amount of surface-inactive SA subtypes was
shown to be increased relative to LA in broncho
alveolar lavage samples obtained from patients with
severe ARDS [18] compared to normal subjects. This
observation was consistent with the numerous animal
studies utilizing models of acute lung injury [19,20].
Moreover, these studies showed that the increased
SA forms within the injured lung contributed to
the lung dysfunction associated with the lung injury.
The results of the present study suggest that in addi-
tion to the obvious biophysical consequences of al-
tered surfactant aggregate forms, the host’s immune
response to various insults may also be compro-
mised. These changes may therefore contribute to
the pathophysiology of the in£ammatory response
occurring within the injured lung.
In our experiments, the whole lung lavage fraction,
or ‘total surfactant’ obtained from normal adult rats
inhibited mitogen-stimulated proliferation of human
PBMCs. Interestingly, the LA and SA isolated from
this total surfactant sample had markedly di¡erent
e¡ects on cellular proliferation when tested sepa-
rately. While LA had minimal e¡ects on prolifera-
tion, SA fractions exhibited a biphasic response.
While exposure to SA at doses of less than 31.25
Wg/ml tended to exert a modest stimulatory e¡ect,
at concentrations of 62.5 Wg/ml and above (of phos-
pholipid equivalents), SA resulted in less T-cell pro-
liferation compared to mitogen-stimulated cells
alone. At the present time it is not possible to suggest
a potential mechanism whereby low doses of SA tend
to enhance proliferation. One can only look to other
immune modulators where, for example, transform-
ing growth factor-L can be a mitogen at low concen-
trations (6 nM) and an anti-mitogen at high doses
Fig. 6. E¡ect of the addition of exogenous IL-2 on the anti-
proliferative e¡ects of SA. The incorporation of [3H]thymidine
(expressed as percentage of CD3 alone) in cultures treated with
increasing concentrations of SA from 7.8 to 62.5 Wg/ml equiva-
lents of phospholipids including 10 IU/ml (A) or 100 IU/ml (B)
of recombinant human IL-2. Group mean of pooled data from
experiment conducted on PBMC from three donors.
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(s nM). The results presented here suggest that the
inhibitory e¡ects on proliferation exhibited by the
total surfactant sample may have been due to the
overriding in£uence of the SA component of total
alveolar surfactant. The speci¢c mechanisms respon-
sible for these e¡ects are unknown, although it was
evident that this inhibitory e¡ect was not mitogen-
speci¢c (Fig. 4). That the anti-proliferative activity
was not removed by heating the samples to 95‡C
might lead to the suggestion that the factor(s) re-
sponsible are unlikely to be proteins. However, it
may also be that the interaction with the lipid com-
ponents of SA leads to protection from denaturation
for the factors. One of the de¢nite e¡ects seen in
these experiments was the inhibition of the release
of IL-2 into the supernatant of cultured lymphocytes
which the inhibition of proliferation as the dose of
SA increased. Furthermore, as addition of exogenous
IL-2 not only reversed the inhibitory e¡ects of SA,
but enhanced proliferation with high concentrations
of IL-2 added, it is likely that SA inhibited lympho-
cyte proliferation via inhibiting IL-2 release from the
stimulated cells.
In our previous studies evaluating the e¡ects of
surfactant components on lymphocyte proliferation,
we utilized puri¢ed SP-A and/or SP-D. These studies
showed similar inhibitory e¡ects of these proteins on
human PBMC proliferation as those observed with
the SA in the present study [7,8]. Other studies have
shown that surfactant phospholipids alone inhibited
T-cell proliferation [14,15,21]. Based on current data,
it appears that the e¡ects of total surfactant on lym-
phocyte proliferation may di¡er compared to those
e¡ects observed with the individual subfractions iso-
lated from alveolar surfactant. The reason for these
di¡erences are likely related to the nature of the ma-
terial being tested in the various experiments. For
example, the majority of SP-A is contained in the
LA fraction of alveolar surfactant (Fig. 2), although
LA had no signi¢cant e¡ect on T-lymphocyte prolif-
eration (Fig. 3A). Alveolar SP-A is thought to be
closely associated with multilamellar and tubular
myelin-like structures. This lipid association may
serve to inactivate the immune-modulating properties
of SP-A by preventing its accessibility to the cells in
culture. On the other hand, SP-A was present in sig-
ni¢cantly lower amounts within the SA fractions,
although this protein may not be as tightly associ-
ated with the lipid components of the small vesicular
structures making up SA. SP-A may be more acces-
sible to the responder cells in culture and therefore
exert e¡ects somewhat similar to puri¢ed SP-A. In
addition, since the Western blots of SP-D showed
variable amounts of this protein in the di¡erent
batches of LA and SA utilized in this study, it is
unlikely that SP-D was a major factor responsible
for the results of our experiments. The phospholipid
pro¢les of both LA and SA were also quite similar,
suggesting that a speci¢c phospholipid component of
the aggregate forms did not account for the di¡er-
ences observed between the aggregate forms.
Although lysophosphatidylcholine (LPC) was ob-
served to be slightly higher in SA compared to LA,
separate experiments in which the speci¢c e¡ects of
LPC on T-cell proliferation indicated that there was
no signi¢cant e¡ect of LPC on anti-CD3-stimulated
T-cell proliferation (data not shown). Therefore,
based on the present observations it is not possible
to propose with any certainty what the nature of the
anti-proliferative factor(s) are responsible for the SA
e¡ect. It may be that the surfactant-associated pro-
teins are important and that their composition, as
well as their conformation within the di¡erent aggre-
gate subtypes within the alveolar space, are critical.
Further studies evaluating the speci¢c mechanisms
involving in these protein^cellular interactions are
required.
In view of the abundant evidence of altered sur-
factant aggregate forms in various disease states, it is
tempting to speculate on the relevance of these in
vitro ¢ndings in relation to the in vivo situation. In
normal lungs, the relative proportion of surfactant
aggregate forms within the airspace is quite consis-
tent among various species, and likely contributes to
the maintenance of the hyporesponsive state of lym-
phocytes within the lung. In acute lung injury, in-
cluding patients with ARDS, a signi¢cant increase
in the SA subfraction within the airspace occurs as
injury progresses. These aggregate changes may af-
fect the host’s in£ammatory response either in a pos-
itive or negative manner. In the latter situation, for
example, these changes may represent a major factor
contributing to a host’s maladaptive in£ammatory
response and the subsequent acute lung injury. A
more extensive evaluation of the surfactant system
at di¡erent stages of lung injury, and correlation of
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these changes with cellular immune responses, are
required in order to determine the speci¢c role of
the surfactant system in this complex immune/in£am-
matory response. Results of the present study repre-
sent an important link between previous in vitro
studies utilizing speci¢c surfactant components, and
the alveolar surfactant forms as they exist within the
alveolar space in vivo.
In summary, we have evaluated the e¡ects of large
and small surfactant aggregates on mitogen-stimu-
lated T-lymphocyte proliferation. LA fractions were
able to reduce surface tension but had no e¡ect on
lymphocyte proliferation. The surface-inactive SA
fraction had signi¢cant, albeit biphasic e¡ects on
lymphocyte proliferation. We speculate that SA
may play an important role in the regulation of lym-
phocyte activation and proliferation within the lung,
and that these changes may contribute to the patho-
physiology of various in£ammatory lung diseases.
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